HIGHLIGHTS
- who: Roma Pahwa from the Institute, National Institutes of Health, Bethesda, MD, USA have published the Article: Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma, in the Journal: (JOURNAL) of 14/02/2022
- what: The authors focused specifically on these pathways as SNX2112 antitumor activity has been shown to be mediated by PI3K/AKT and MEK/ ERK1/2 pathways in other cancers including METamplified gastric and lung cancers, HER kinase dependent cancers, multiple myeloma and other hematologic tumors ; however, it is entirely possible that other HSP90 clients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.